Free Trial

Coya Therapeutics (COYA) SEC Filings & 10K Form

Coya Therapeutics logo
$6.03 -0.04 (-0.66%)
(As of 11/20/2024 ET)

Recent Coya Therapeutics SEC Filings

DateFilerForm TypeView
11/20/2024
4:15 PM
Coya Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
11/14/2024
5:08 PM
Coya Therapeutics (Issuer)
SNYDER DAVID S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/12/2024
2:37 PM
Coya Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/06/2024
7:06 AM
Coya Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2024
7:02 AM
Coya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2024
4:02 PM
Coya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2024
12:27 PM
Coya Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
11/04/2024
10:42 AM
Coya Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
10/31/2024
3:42 PM
Coya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/29/2024
7:00 AM
Coya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/22/2024
8:08 AM
Coya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/19/2024
8:10 AM
Coya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2024
7:04 AM
Coya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2024
7:13 AM
Coya Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/15/2024
5:10 AM
Coya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/24/2024
4:31 PM
Coya Therapeutics (Filer)
Form 424B3
06/23/2024
11:15 PM
Coya Therapeutics (Filer)
Form EFFECT
06/05/2024
7:00 PM
Coya Therapeutics (Issuer)
Grossman Fred (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
7:00 PM
Berman Howard (Reporting)
Coya Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
7:00 PM
Coya Therapeutics (Issuer)
SNYDER DAVID S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
7:00 AM
Coya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/09/2024
3:20 PM
Coya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/08/2024
4:21 PM
Coya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/28/2024
3:40 PM
Coya Therapeutics (Filer)
Form ARS
03/28/2024
3:30 PM
Coya Therapeutics (Filer)
Form DEF 14A
03/28/2024
3:35 PM
Coya Therapeutics (Filer)
Form DEFA14A
03/19/2024
7:21 AM
Coya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/19/2024
7:27 AM
Coya Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/05/2024
7:00 PM
Coya Therapeutics (Issuer)
Lee Ann (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2024
3:46 PM
Coya Therapeutics (Subject)
GREENLIGHT CAPITAL INC (Filed by)
Form SC 13G/A
02/07/2024
5:55 PM
Coya Therapeutics (Subject)
HIRSCHMAN ORIN (Filed by)
Form SC 13G/A
02/02/2024
7:00 PM
Berman Howard (Reporting)
Coya Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
7:00 PM
Coya Therapeutics (Issuer)
SNYDER DAVID S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
7:00 PM
Coya Therapeutics (Issuer)
Grossman Fred (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
5:30 PM
Coya Therapeutics (Issuer)
Villalobos Anabella (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
5:30 PM
Coya Therapeutics (Issuer)
Lee Ann (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
5:30 PM
Coya Therapeutics (Issuer)
GOLDSTEIN DOV A MD (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
5:30 PM
Coya Therapeutics (Issuer)
Garren Hideki (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
5:30 PM
Coya Therapeutics (Issuer)
Weinand Dieter (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
7:15 AM
Coya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/15/2024
11:15 PM
Coya Therapeutics (Filer)
Form EFFECT
Trump said you could learn something from this man (Ad)

Early Warning: A Deep Crack Is Forming In The US Economy Stocks are booming thanks to Trump’s landslide victory. Yet one former Trump advisor says the picture is less rosy than it seems. “I’ve found a deep crack forming in the foundations of the US economy,” he says. “And before too long, it could tear our country apart.” It’s critical you learn more today, BEFORE it impacts your money and your retirement.

Here’s everything you need to know.
01/04/2024
3:46 PM
Coya Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
01/04/2024
3:05 PM
Coya Therapeutics (Issuer)
ROSS WILBUR L JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/29/2023
7:00 AM
Coya Therapeutics (Issuer)
ROSS WILBUR L JR (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
12/20/2023
8:46 AM
Coya Therapeutics (Filer)
Form D
Notice of Exempt Offering of Securities 
12/20/2023
7:35 AM
Coya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/06/2023
6:30 AM
Coya Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:COYA) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners